SERVICES

Market access support designed to move from strategy to execution.

Modular advisory support for Pharma, MedTech and Life Sciences teams preparing market entry, navigating reimbursement or accelerating adoption.

01

Market Entry & Launch Strategy

Market landscape assessment, access barriers, launch sequencing, entry scenarios, opportunity prioritisation and cross-functional action planning.

02

Pricing & Reimbursement

Reimbursement pathway assessment, pricing logic, comparator analysis, negotiation preparation and value proposition alignment.

03

HTA / HEOR Positioning

Evidence-gap analysis, HTA narrative, economic value framing, budget-impact thinking and decision-relevant evidence prioritisation.

04

Regional & Hospital Access

Regional dynamics, formulary and hospital access pathways, local decision-making, procurement routes and implementation priorities.

05

Stakeholder Mapping & Engagement

Identification and prioritisation of payers, institutions, clinicians, procurement actors, KOLs and other access influencers.

06

MedTech Access & Adoption

Access pathways for devices and technologies, hospital value proposition, mini-HTA thinking, procurement strategy and adoption planning.

07

Early Access & Pre-Launch Planning

Early access route assessment, pre-launch stakeholder needs, evidence preparation and risk/opportunity mapping before commercial launch.

08

Commercial Adoption Strategy

Conversion of access strategy into an executable go-to-market plan focused on uptake, account priorities, channel strategy and measurable milestones.

TAILORED SUPPORT

Need a focused project rather than a large consulting programme?

Engagements can be scoped around one decision, one launch, one geography or a broader market-access workstream.

Define the scope